HIPK2: A multitalented partner for transcription factors in DNA damage response and development

Biochemistry and Cell Biology

Volumn 85, Issue 4, 2007, Pages 411-418

  Rinaldo, Cinzia ^a   Prodosmo, Andrea ^a   Siepi, Francesca ^a   Soddu, Silvia ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Apoptosis; HIPK2; p53; Phosphorylation; Transcription

Indexed keywords

CELL DEATH; CHARACTERIZATION; DNA; ENZYMES; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION;

DAMAGE RESPONSE; HIPK2; P53; POST-TRANSLATIONAL MODIFICATION;

TRANSCRIPTION FACTORS;

HOMEODOMAIN INTERACTING PROTEIN KINASE 2; PROTEIN P53; TRANSCRIPTION FACTOR;

AMINO TERMINAL SEQUENCE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; DNA DAMAGE; EMBRYO DEVELOPMENT; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GROWTH DISORDER; HUMAN; NONHUMAN; PROTEIN DEGRADATION; PROTEIN STRUCTURE; SHORT SURVEY; SUMOYLATION; UBIQUITINATION;

CARRIER PROTEINS; DNA DAMAGE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; PROTEIN-SERINE-THREONINE KINASES; TRANSCRIPTION FACTORS;

EID: 34948910811     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/O07-071     Document Type: Short Survey

References (48)

1. Aikawa, Y., Nguyen, L.A., Isono, K., Takakura, N., Tagata, Y., Schmitz, M.L., Koseki, H., and Kitabayashi, I. 2006. Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation. EMBO J. 25: 3955-3965. doi:10.1038/sj.emboj.7601273.
2. Budhram-Mahadeo, V., Morris, P.J., Smith, M.D., Midgley, C.A., Boxer, L.M., and Latchman, D.S. 1999. p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor. J. Biol. Chem. 274: 15237-15244. doi:10.1074/jbc.274.21.15237.
3. Cecchinelli, B., Porrello, A., Lazzari, C., Gradi, A., Bossi, G., D'Angelo, M., Sacchi, A., and Soddu, S. 2006a. Ser58 of mouse p53 is the homologue of human Ser46 and is phosphorylated by HIPK2 in apoptosis. Cell Death Differ. 13: 1994-1997. doi:10.1038/sj.cdd.4401933.
4. Cecchinelli, B., Lavra, L., Rinaldo, C., Iacovelli, S., Gurtner, A., Gasbarri, A., et al. 2006b. Repression of the anti-apoptotic molecule Galectin-3 by HIPK2-activated p53 is required for p53-induced apoptosis. Mol. Cell. Biol. 26: 4746-4757. doi:10.1128/MCB.00959-05.
5. Choi, C.Y., Kim, Y.H., Kwon, H.J., and Kim, Y. 1999. The homeodomain protein NK-3 recruits Groucho and a histone deacetylase complex to repress transcription. J. Biol. Chem. 274: 33194-33197. doi:10.1074/jbc.274.47. 33194.
6. Choi, C.Y., Kim, Y.H., Kim, Y.O., Park, S.J., Kim, E.A., Riemenschneider, W., et al. 2005. Phosphorylation by the DHIPK2 protein kinase modulates the corepressor activity of Groucho. J. Biol. Chem. 280: 21427-21436. doi:10.1074/jbc.M500496200.
7. Dauth, I., Kruger, J., and Hofmann, T.G. 2007. Homeodomain-interacting protein kinase 2 is the ionizing radiation-activated p53 serine 46 kinase and is regulated by ATM. Cancer Res. 67: 2274-2279. doi:10.1158/0008-5472.CAN- 06-2884.
8. Di Stefano, V., Rinaldo, C., Sacchi, A., Soddu, S., and D'Orazi, G. 2004. Homeodomain-interacting protein kinase-2 activity and p53 phosphorylation are critical events for cisplatin-mediated apoptosis. Exp. Cell Res. 293: 311-320. doi:10.1016/j.yexcr.2003.09.032.
9. Di Stefano, V., Soddu, S., Sacchi, A., and D'Orazi, G. 2005. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage. Oncogene, 24: 5431-5442. doi:10.1038/sj.onc.1208717.
10. D'Orazi, G., Cecchinelli, B., Bruno, T., Manni, I., Higashimoto, Y., Saito, S., et al. 2002. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser46 and mediates apoptosis. Nat. Cell Biol. 4: 11-19. doi:10.1038/ncb714.
11. Frasca, F., Rustighi, A., Malaguarnera, R., Altamura, S., Vigneri, P., Del Sal, G., et al. 2006. HMGA1 inhibits the function of p53 family members in thyroid cancer cells. Cancer Res. 66: 2980-2989. doi:10.1158/0008-5472. CAN-05-2637.
12. Gostissa, M., Hofmann, T.G., Will, H., and Del Sal, G. 2003. Regulation of p53 functions: let's meet at the nuclear bodies. Curr. Opin. Cell Biol. 15: 351-357. doi:10.1016/S0955-0674(03)00038-3.
13. Gresko, E., Moller, A., Roscic, A., and Schmitz, M.L. 2005. Covalent modification of human homeodomain interacting protein kinase 2 by SUMO-1 at lysine 25 affects its stability. Biochem. Biophys. Res. Commun. 329: 1293-1299. doi:10.1016/j.bbrc.2005.02.113.
14. Gresko, E., Roscic, A., Ritterhoff, S., Vichalkovski, A., Del Sal, G., and Schmitz, M.L. 2006. Autoregolatory control of the p53 response by caspase-mediated processing of HIPK2. EMBO J. 25: 1883-1894. doi:10.1038/sj.emboj.7601077.
15. Grooteclaes, M., Deveraux, Q., Hildebrand, J., Zhang, Q., Goodman, R.H., and Frisch, S.M. 2003. C-terminal-binding protein corepresses epithelial and proapoptotic gene expression programs. Proc. Natl. Acad. Sci. U.S.A. 100: 4568-4573. doi:10.1073/pnas.0830998100.
16. Harada, J., Kokura, K., Kanei-Ishii, C., Nomura, T., Khan, M.M., Kim, Y., and Ishii, S. 2003. Requirement of the co-repressor homeodomain-interacting protein kinase 2 for ski-mediated inhibition of bone morphogenetic protein-induced transcriptional activation. J. Biol. Chem. 278: 38998-39005. doi:10.1074/jbc.M307112200.
17. Hofmann, T.G., Mincheva, A., Lichter, P., Droge, W., and Schmitz, M.L. 2000. Human homeodomain-interacting protein kinase 2 (HIPK2) is a member of the DYRK family of protein kinases and maps to chromosome 7q32-q34. Biochimie, 82: 1123-1127. doi:10.1016/S0300-9084(00)01196-2.
18. Hofmann, T.G., Moller, A., Sirma, H., Zentgraf, H., Taya, Y., Droge, W., Will, H., and Schmitz, M.L. 2002. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat. Cell Biol. 4: 1-10. doi:10.1038/ncb715.
19. Hofmann, T.G., Jaffray, E., Stollberg, N., Hay, R.T., and Will, H. 2005. Regulation of homeodomain-interacting protein kinase 2 (HIPK2) effector function through dynamic small ubiquitin-related modifier-1 (SUMO-1) modification. J. Biol. Chem. 280: 29224-29232. doi:10.1074/jbc.M503921200.
20. Hudson, C.D., Morris, P.J., Latchman, D.S., and Budhram-Mahadeo, V.S. 2005. Brn-3a transcription factor blocks p53-mediated activation of proapoptotic target genes Noxa and Bax in vitro and in vivo to determine cell fate. J. Biol. Chem. 280: 11851-11858. doi:10.1074/jbc.M408679200.
21. Imbriano, C., Gurtner, A., Cocchiarella, F., Di Agostino, S., Basile, V., Gostissa, M., et al. 2005. Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters. Mol. Cell. Biol. 25: 3737-3751. doi:10.1128/MCB.25.9.3737-3751.2005.
22. Isono, K., Nemoto, K., Li, Y., Takada, Y., Suzuki, R., Katsuki, M., Nakagawara, A., and Koseki, H. 2006. Overlapping roles for homeodomain- interacting protein kinases hipk1 and hipk2 in the mediation of cell growth in response to morphogenetic and genotoxic signals. Mol. Cell. Biol. 26: 2758-2771. doi:10.1128/MCB.26.7.2758-2771.2006.
23. Kanei-Ishii, C., Ninomiya-Tsuji, J., Tanikawa, J., Nomura, T., Ishitani, T., Kishida, S., et al. 2004. Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK. Genes Dev. 18: 816-829. doi:10.1101/gad.1170604.
24. Kim, Y.H., Choi, C.Y., Lee, S.J., Conti, M.A., and Kim, Y. 1998. Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors. J. Biol. Chem. 273: 25875-25879. doi:10.1074/jbc.273.40.25875.
25. Kim, E.J., Park, J.S., and Um, S.J. 2002. Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family in vivo. J. Biol. Chem. 277: 32020-32028. doi:10.1074/jbc. M200153200.
26. Kim, E.A., Noh, Y.T., Ryu, M.J., Kim, H.T., Lee, S.E., Kim, C.H., et al. 2006. Phosphorylation and transactivation of Pax6 by homeodomain-interacting protein kinase 2. J. Biol. Chem. 281: 7489-7497. doi:10.1074/jbc. M507227200.
27. Kondo, S., Lu, Y., Debbas, M., Lin, A.W., Sarosi, I., Itie, A., et al. 2003. Characterization of cells and gene-targeted mice deficient for the p53-binding kinase homeodomain-interacting protein kinase 1 (HIPK1). Proc. Natl. Acad. Sci. U.S.A. 100: 5431-5436. doi:10.1073/pnas.0530308100.
28. Lan, H.C., Li, H.J., Lin, G., Lai, P.Y., and Chung, B.C. 2007. Cyclic AMP stimulates SF-1-dependent CYP11A1 expression through homeodomain-interacting protein kinase 3-mediated Jun N-terminal kinase and c-Jun phosphorylation. Mol. Cell. Biol. 27: 2027-2036. doi:10.1128/MCB.02253-06.
29. Li, Q., Wang, X., Wu, X., Rui, Y., Liu, W., Wang, J., et al. 2007. Daxx cooperates with the Axin/HIPK2/p53 complex to induce cell death. Cancer Res. 67: 66-74. doi:10.1158/0008-5472.CAN-06-1671.
30. Manning, G., Whyte, D.B., Martinez, R., Hunter, T., and Sudarsanam, S. 2002. The protein kinase complement of the human genome. Science, 298: 1912-1934. doi:10.1126/science.1075762.
31. Mayo, L.D., Seo, Y.R., Jackson, M.W., Smith, M.L., Rivera Guzman, J., Korgaonkar, C.K., and Donner, D.B. 2005. Phosphorylation of human p53 at Ser46 determines promoter selection and whether apoptosis is attenuated or amplified. J. Biol. Chem. 280: 25953-25959. doi:10.1074/jbc.M503026200.
32. Moller, A., Sirma, H., Hofmann, T.G., Rueffer, S., Klimczak, E., Droge, W., Will, H., and Schmitz, M.L. 2003. PML is required for homeodomain- interacting protein kinase 2 (HIPK2)-mediated p53 phosphorylation and cell cycle arrest but is dispensable for the formation of HIPK domains. Cancer Res. 63: 4310-4314.
33. Oda, K., Arakawa, H., Tanaka, T., Matsuda, K., Tanikawa, C., Mori, T., et al. 2000. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phsphorylated p53. Cell, 102: 849-862. doi:10.1016/S0092-8674(00)00073-8.
34. Pierantoni, G.M., Fedele, M., Pentimalli, F., Benvenuto, G., Pero, R., Viglietto, G., et al. 2001. High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth. Oncogene, 20: 6132-6141. doi:10.1038/sj.onc.1204635.
35. Pierantoni, G.M., Rinaldo, C., Esposito, F., Mottolese, M., Soddu, S., and Fusco, A. 2006. High Mobility Group A1 (HMGA1) proteins interact with p53 and inhibit its apoptotic activity. Cell Death Differ. 13: 1554-1563. doi:10.1038/sj.cdd.4401839.
36. Pierantoni, G.M., Rinaldo, C., Mottolese, M., Di Benedetto, A., Esposito, F., Soddu, S., and Fusco, A. 2007. High-mobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2. J. Clin. Invest. 117: 693-702. doi:10.1172/JCI29852.
37. Rechsteiner, M., and Rogers, S.W. 1996. PEST sequences and regulation by proteolysis. Trends Biochem. Sci. 21: 267-271. doi:10.1016/0968-0004(96) 10031-1.
38. Reeves, R. 2000. Structure and function of the HMGI(Y) family of architectural transcriptionfactors. Environ. Health Perspect. 108: 803-809. doi:10.2307/3454310.
39. Rinaldo, C., Prodosmo, A., Mancini, F., Iacovelli, S., Sacchi, A., Moretti, F., and Soddu, S. 2007. MDM2-regulated degradation of HIPK2 prevents p53 Ser46 phosphorylation and DNA damage-induced apoptosis. Mol. Cell, 25: 739-750. doi:10.1016/j.molcel.2007.02.008.
40. Roscic, A., Moller, A., Calzado, M.A., Renner, F., Wimmer, V.C., Gresko, E., Ludi, K.S., and Schmitz, M.L. 2006. Phosphorylation-dependent control of Pc2 SUMO E3 ligase activity by its substrate protein HIPK2. Mol. Cell, 24: 77-89. doi:10.1016/j.molcel.2006.08.004.
41. Rui, Y., Xu, Z., Lin, S., Li, Q., Rui, H., Luo, W., et al. 2004. Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation. EMBO J. 23: 4583-4594. doi:10.1038/sj.emboj.7600475.
42. Sung, K.S., Go, Y.Y., Ahn, J.H., Kim, Y.H., Kim, Y., and Choi, C.Y. 2005. Differential interactions of the homeodomain-interacting protein kinase 2 (HIPK2) by phosphorylation-dependent sumoylation. FEBS Lett. 579: 3001-3008. doi:10.1016/j.febslet.2005.04.053.
43. Vousden, K.H., and Lu, X. 2002. Live or let die: the cell's response to p53. Nat. Rev. Cancer, 2: 594-604. doi:10.1038/nrc864.
44. Whitmarsh, A.J., and Davis, R.J. 2000. Regulation of transcription factor function by phosphorylation. Cell. Mol. Life Sci. 57: 1172-1183. doi:10.1007/PL00000757.
45. Wiggins, A.K., Wei, G., Doxakis, E., Wong, C., Tang, A.A., Zang, K., et al. 2004. Interaction of Brn3a and HIPK2 mediates transcriptional repression of sensory neuron survival. J. Cell Biol. 167: 257-267. doi:10.1083/jcb. 200406131.
46. Workman, J.L., and Kingston, R.E. 1998. Alteration of nucleosome structure as a mechanism of transcriptional regulation. Annu. Rev. Biochem. 67: 545-579. doi:10.1146/annurev.biochem.67.1.545.
47. Zhang, Q., Yoshimatsu, Y., Hildebrand, J., Frisch, S.M., and Goodman, R.H. 2003. Homeodomain interacting protein kinase 2 promotes apoptosis by down-regulating the transcriptional co-repressor CtBP. Cell, 115: 177-186. doi:10.1016/S0092-8674(03)00802-X.
48. Zhang, J., Pho, V., Bonasera, S.J., Holtzman, J., Tang, A.T., Hellmuth, J., et al. 2007. Essential function of HIPK2 in TGFbeta-dependent survival of midbrain dopamine neurons. Nat. Neurosci. 10: 77-86. doi:10.1038/nn1816.